Skip to content

Sight Sciences, Inc. SGHT Accrued Liabilities & Other

Accrued Liabilities & Other at other companies

Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$110.85M+45.1%

Other financials

Income statement

See full
Revenue$19.7M+12.5%
Gross profit$17.0M+12.5%
Operating income-$12.4M+10.4%
Net income-$13.0M+8.3%
EPS (diluted)-$0.24+14.3%

Balance sheet

See full
Cash & equivalents$85.0M-21.9%
Total debt$40.9M+1.1%
Total equity$53.9M-30.6%
Total assets$109.7M-15.4%

Cash flow

See full
Operating cash flow-$7.0M+39.4%
CapEx$60.0K
Free cash flow-$7.1M+38.9%

Valuation

See full
Market cap$294.9M+35.0%
Enterprise value$250.83M+59.0%
P/S3.7×+0.8×

Profitability

See full
Gross margin86.2%+0.5pp
Operating margin-44.8%-10.2pp
Net margin-46.8%-9.6pp
FCF margin-31.9%+0.2pp

Returns & leverage

See full
Return on equity-56.6%+4.3pp
Debt / equity0.8×+0.2×
Current ratio5.9×-4.6×

Where this comes from

Reported directly by Sight Sciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent.

The official record: Sight Sciences, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sight Sciences, Inc.'s accrued liabilities & other.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sight Sciences, Inc.'s accrued liabilities & other?
Sight Sciences, Inc. (SGHT) reported accrued liabilities & other of $9.19M in Q1 2026.
How has Sight Sciences, Inc.'s accrued liabilities & other changed year-over-year?
Sight Sciences, Inc.'s accrued liabilities & other increased by 117.1% year-over-year, from $4.23M to $9.19M.
What is the long-term trend for Sight Sciences, Inc.'s accrued liabilities & other?
Over 5 years (2020 to 2025), Sight Sciences, Inc.'s accrued liabilities & other has grown at a 3.2% compound annual growth rate (CAGR), from $3.09M to $3.61M.
What does accrued liabilities & other mean?
Combined accrued expenses and miscellaneous current liabilities not classified in specific categories.